000 01371 a2200397 4500
005 20250517142415.0
264 0 _c20170921
008 201709s 0 0 eng d
022 _a1875-533X
024 7 _a10.2174/0929867324666170303162100
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMusumeci, Francesca
245 0 0 _aPyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors.
_h[electronic resource]
260 _bCurrent medicinal chemistry
_c2017
300 _a2059-2085 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xchemistry
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aDrug Design
650 0 4 _aHumans
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aMolecular Docking Simulation
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xchemistry
650 0 4 _aPyrimidines
_xchemistry
650 0 4 _aPyrroles
_xchemistry
650 0 4 _aStructure-Activity Relationship
700 1 _aSanna, Monica
700 1 _aGrossi, Giancarlo
700 1 _aBrullo, Chiara
700 1 _aFallacara, Anna Lucia
700 1 _aSchenone, Silvia
773 0 _tCurrent medicinal chemistry
_gvol. 24
_gno. 19
_gp. 2059-2085
856 4 0 _uhttps://doi.org/10.2174/0929867324666170303162100
_zAvailable from publisher's website
999 _c26941969
_d26941969